By
SAN DIEGO, Jan. 3, 2012 /PRNewswire-/- Volcano Corporation
(NASDAQ: VOLC), a leading developer and manufacturer of
precision intravascular diagnosis and therapy guidance tools
designed to enhance the treatment of coronary and peripheral
vascular disease, said today that it will be participating in
the 30th Annual J.P. Morgan Healthcare Conference on Tuesday,
January 10.
The presentation by Scott Huennekens, president and chief
executive officer, will begin at 9:30 a.m., Pacific Standard
Time (12:30 p.m., Eastern Standard Time). The presentation
will be available through the conference website at
http://jpmorgan.metameetings.com/webcasts/healthcare12/directlink?ticker=VOLCand via the company's website at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device
industry with a broad suite of technologies that make imaging
and therapy simpler, more informative and less invasive. Our
products empower physicians around the world with a new
generation of analytical tools that deliver more meaningful
information-using light and sound as the guiding elements.
Founded in cardiovascular care and expanding into other
specialties, Volcano is changing the assumption about what is
possible in improving patient outcomes by combining imaging
and therapy together. For more information, visit the
company's website at www.volcanocorp.com.
SOURCE Volcano Corporation
News Provided by Acquire Media
| distribué par | Ce noodl a été diffusé par Volcano Corporation et initialement mise en ligne sur le site http://www.volcanocorp.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-03 15:11:39 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
| Documents associés | |
| Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast |
